FOOD AND DRUG ADMINISTRATION (FDA) 
Center for Drug Evaluation and Research (CDER) 

Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) Meeting 

FDA White Oak Campus, Building 31, The Great Room (Rm. 1503) 

White Oak Conference Center, Silver Spring, Maryland 

 

 

January 10, 2013 

MEETING ROSTER 

 

 

 

Edward W. Gregg, PhD 
Chief, Epidemiology and Statistics Branch 
Division of Diabetes Translation 
Centers for Disease Control and Prevention (CDC) 
Atlanta, Georgia  
 

ACTING DESIGNATED FEDERAL OFFICER (Non-Voting)  
 
Caleb D. Briggs, PharmD 
Division of Advisory Committee and Consultant Management  
Office of Executive Programs, CDER, FDA 
 
ENDOCRINOLOGIC AND METABOLIC DRUGS ADVISORY COMMITTEE MEMBERS (Voting) 
                                                                                                  
Erica H. Brittain, PhD 
Mathematical Statistician  
Biostatistics Research Branch 
National Institute of Allergy and Infectious  
Diseases (NIAID) 
National Institutes of Health (NIH) 
Bethesda, Maryland 
 
David M. Capuzzi, MD, PhD 
Professor of Medicine and Biochemistry 
Thomas Jefferson University & 
Lankenau Institute for Medical Research 
Philadelphia, Pennsylvania 
 
ENDOCRINOLOGIC AND METABOLIC DRUGS ADVISORY COMMITTEE MEMBER  
(Non-Voting) 
 
Mads F. Rasmussen, MD, PhD 
(Industry Representative) 
Executive Director 
Diabetes - Clinical Development and Research 
Clinical Development, Medical and Regulatory Affairs 
Novo Nordisk Inc.  
Princeton, New Jersey 
 
TEMPORARY MEMBERS (Voting) 
 
Nakela Cook, MD, MPH, FACC 
Clinical Medical Officer 
Clinical Application and Prevention Branch 
National Heart, Lung, and Blood Institute (NHLBI), NIH 
Bethesda, Maryland 

David W. Cooke, MD 
Associate Professor of Pediatrics 
Division of Pediatric Endocrinology 
Director, Pediatric Endocrine Fellowship Training 
Program  
Johns Hopkins University School of Medicine 
Baltimore, Maryland 

 

Page 1 of 3 

Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) Meeting 

FOOD AND DRUG ADMINISTRATION (FDA) 
Center for Drug Evaluation and Research (CDER) 

 

 

January 10, 2013 

MEETING ROSTER (cont.) 

 

 
 
TEMPORARY MEMBERS (Voting) 
 
William R. Hiatt, MD, FACP 
Professor of Medicine 
Division of Cardiology 
University of Colorado School of Medicine 
President, Colorado Prevention Center (CPC) Clinical 
Research 
Aurora, Colorado 
  
Sanjay Kaul, MD 
Director, Fellowship Training Program in  
Cardiovascular Diseases 
Cedars-Sinai Heart Institute 
Professor, David Geffen School of Medicine at UCLA 
Division of Cardiology 
Cedar Sinai Medical Center 
Los Angeles, California 
 
Rebecca Killion 
(Patient Representative) 
Washington, District of Columbia 
 

William C. Knowler, MD, PhD, MPH 
Chief, Diabetes Epidemiology and Clinical  
Research Section 
National Institute of Diabetes and Digestive and Kidney 
Diseases (NIDDK), NIH 
Phoenix, Arizona 
 
Julia B. Lewis, MD 
Professor of Medicine 
Department of Nephrology 
Vanderbilt University School of Medicine 
Nashville, Tennessee 
 

David E. Malarkey, DVM, PhD, DACVP 
Head, National Toxicology Program Pathology Group 
Cellular and Molecular Pathology Branch 
National Institute of Environmental Health Sciences 
(NIEHS), NIH 
Research Triangle Park, North Carolina 

Paul M. Palevsky, MD 
Chief, Renal Section 
Veterans Affairs Pittsburgh Healthcare System 
Professor of Medicine and Clinical & Translational 
Science 
University of Pittsburgh School of Medicine 
Pittsburgh, Pennsylvania 

Michael A. Proschan, PhD 
Mathematical Statistician 
Biostatistics Research Branch 
NIAID, NIH 
Bethesda, Maryland 
 
Peter J. Savage, MD 
Senior Advisor to the Director 
Division of Diabetes, Endocrinology & Metabolic 
Diseases (DDEMD) 
NIDDK, NIH 
Bethesda, Maryland 

Abraham Thomas, MD, MPH, FACP 
(Acting Chairperson) 
Division Head, Endocrinology, Diabetes, Bone, and 
Mineral Disorders 
Henry Ford Hospital, Whitehouse Chair of 
Endocrinology 
Detroit, Michigan  
 

Page 2 of 3 

Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) Meeting 

FOOD AND DRUG ADMINISTRATION (FDA) 
Center for Drug Evaluation and Research (CDER) 

 

 

January 10, 2013 

MEETING ROSTER (cont.) 

 

 
 
FDA PARTICIPANTS (Non-Voting) 
 
Curtis J. Rosebraugh, MD, MPH 
Director 
Office of Drug Evaluation II (ODE-II)  
Office of New Drugs (OND), CDER, FDA  

Jean-Marc Guettier, MDCM 
Clinical Team Leader 
DMEP, ODE-II, OND, CDER, FDA 
 
Mat Soukop, PhD 
Team Leader 
Division of Biometrics 7 
Office of Biostatistics (OB) 
Office of Translational Sciences (OTS), CDER, FDA 

 

  
 
Mary H. Parks, MD 
Director  
Division of Metabolism and Endocrinology Products 
(DMEP), ODE-II, OND, CDER, FDA 
 
Hyon (KC) Kwon, PharmD, MPH 
Clinical Reviewer 
DMEP, ODE-II, OND, CDER, FDA 
 
 

Page 3 of 3 

